rs1889790

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000085.5(CLCNKB):​c.642A>C​(p.Ala214Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.826 in 151,746 control chromosomes in the GnomAD database, including 53,688 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 53688 hom., cov: 31)
Exomes 𝑓: 0.92 ( 614566 hom. )
Failed GnomAD Quality Control

Consequence

CLCNKB
NM_000085.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -2.93

Publications

10 publications found
Variant links:
Genes affected
CLCNKB (HGNC:2027): (chloride voltage-gated channel Kb) The protein encoded by this gene is a member of the family of voltage-gated chloride channels. Chloride channels have several functions, including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport. This gene is expressed predominantly in the kidney and may be important for renal salt reabsorption. Mutations in this gene are associated with autosomal recessive Bartter syndrome type 3 (BS3). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
CLCNKB Gene-Disease associations (from GenCC):
  • Bartter disease type 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Bartter disease type 4B
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Gitelman syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 1-16048569-A-C is Benign according to our data. Variant chr1-16048569-A-C is described in ClinVar as [Benign]. Clinvar id is 504915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.93 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKBNM_000085.5 linkc.642A>C p.Ala214Ala synonymous_variant Exon 7 of 20 ENST00000375679.9 NP_000076.2 P51801-1A8K8H0
CLCNKBNM_001165945.2 linkc.-403A>C upstream_gene_variant NP_001159417.2 P51801-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKBENST00000375679.9 linkc.642A>C p.Ala214Ala synonymous_variant Exon 7 of 20 1 NM_000085.5 ENSP00000364831.5 P51801-1

Frequencies

GnomAD3 genomes
AF:
0.826
AC:
125196
AN:
151630
Hom.:
53659
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.571
Gnomad AMI
AF:
0.913
Gnomad AMR
AF:
0.896
Gnomad ASJ
AF:
0.880
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.936
Gnomad FIN
AF:
0.918
Gnomad MID
AF:
0.896
Gnomad NFE
AF:
0.924
Gnomad OTH
AF:
0.848
GnomAD2 exomes
AF:
0.907
AC:
227189
AN:
250522
AF XY:
0.912
show subpopulations
Gnomad AFR exome
AF:
0.559
Gnomad AMR exome
AF:
0.939
Gnomad ASJ exome
AF:
0.890
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.919
Gnomad NFE exome
AF:
0.926
Gnomad OTH exome
AF:
0.906
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.915
AC:
1337179
AN:
1461102
Hom.:
614566
Cov.:
63
AF XY:
0.917
AC XY:
666207
AN XY:
726852
show subpopulations
African (AFR)
AF:
0.549
AC:
18385
AN:
33458
American (AMR)
AF:
0.932
AC:
41642
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.884
AC:
23093
AN:
26130
East Asian (EAS)
AF:
1.00
AC:
39673
AN:
39690
South Asian (SAS)
AF:
0.924
AC:
79715
AN:
86238
European-Finnish (FIN)
AF:
0.918
AC:
48961
AN:
53340
Middle Eastern (MID)
AF:
0.876
AC:
4819
AN:
5504
European-Non Finnish (NFE)
AF:
0.923
AC:
1026650
AN:
1111704
Other (OTH)
AF:
0.899
AC:
54241
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
6639
13278
19917
26556
33195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21478
42956
64434
85912
107390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.826
AC:
125274
AN:
151746
Hom.:
53688
Cov.:
31
AF XY:
0.829
AC XY:
61457
AN XY:
74172
show subpopulations
African (AFR)
AF:
0.571
AC:
23556
AN:
41266
American (AMR)
AF:
0.896
AC:
13689
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.880
AC:
3051
AN:
3468
East Asian (EAS)
AF:
0.999
AC:
5110
AN:
5114
South Asian (SAS)
AF:
0.936
AC:
4511
AN:
4818
European-Finnish (FIN)
AF:
0.918
AC:
9726
AN:
10590
Middle Eastern (MID)
AF:
0.898
AC:
264
AN:
294
European-Non Finnish (NFE)
AF:
0.924
AC:
62749
AN:
67904
Other (OTH)
AF:
0.850
AC:
1793
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
899
1798
2698
3597
4496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
864
1728
2592
3456
4320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.874
Hom.:
21208
Bravo
AF:
0.810
Asia WGS
AF:
0.948
AC:
3294
AN:
3478
EpiCase
AF:
0.917
EpiControl
AF:
0.922

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala214Ala in exon 7 of CLCNKB: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 99.93% (8628/8634) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org; dbSNP rs1889790). -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Bartter disease type 3 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bartter disease type 4B Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.64
DANN
Benign
0.70
PhyloP100
-2.9
PromoterAI
0.077
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1889790; hg19: chr1-16375064; COSMIC: COSV65161020; COSMIC: COSV65161020; API